Cargando…
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity. Here we report our modelled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is...
Autores principales: | Vankadari, Naveen, Wilce, Jacqueline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103712/ https://www.ncbi.nlm.nih.gov/pubmed/32178593 http://dx.doi.org/10.1080/22221751.2020.1739565 |
Ejemplares similares
-
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
por: Vankadari, Naveen
Publicado: (2020) -
Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022) -
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
por: Walls, Alexandra C, et al.
Publicado: (2016) -
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
por: Watanabe, Yasunori, et al.
Publicado: (2020) -
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2
Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)